Catalyst Pharmaceuticals (CPRX) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Catalyst Pharmaceuticals (CPRX) over the last 14 years, with Q3 2025 value amounting to -$1000.0.
- Catalyst Pharmaceuticals' Accumulated Depreciation & Amortization rose 9974.29% to -$1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1000.0, marking a year-over-year increase of 9974.29%. This contributed to the annual value of -$304000.0 for FY2024, which is 4901.96% down from last year.
- Latest data reveals that Catalyst Pharmaceuticals reported Accumulated Depreciation & Amortization of -$1000.0 as of Q3 2025, which was up 9974.29% from -$73000.0 recorded in Q2 2025.
- In the past 5 years, Catalyst Pharmaceuticals' Accumulated Depreciation & Amortization registered a high of $133000.0 during Q4 2022, and its lowest value of -$389000.0 during Q3 2024.
- Over the past 5 years, Catalyst Pharmaceuticals' median Accumulated Depreciation & Amortization value was -$73000.0 (recorded in 2025), while the average stood at -$108894.7.
- Per our database at Business Quant, Catalyst Pharmaceuticals' Accumulated Depreciation & Amortization surged by 120000.0% in 2022 and then crashed by 65454.55% in 2023.
- Over the past 5 years, Catalyst Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $21000.0 in 2021, then skyrocketed by 533.33% to $133000.0 in 2022, then plummeted by 253.38% to -$204000.0 in 2023, then crashed by 49.02% to -$304000.0 in 2024, then soared by 99.67% to -$1000.0 in 2025.
- Its Accumulated Depreciation & Amortization was -$1000.0 in Q3 2025, compared to -$73000.0 in Q2 2025 and -$189000.0 in Q1 2025.